… GC include decreasing the expression of proangiogenic ligands … the expression of
vascular endothelial growth factor-… pathways, such as the VEGF-, EGFR- and STAT3-mediated …

… After curative operation, patients were subjected to adjuvant combination chemotherapy. We
… Although the polymorphism has been shown to affect the expression of the VEGF gene, the …

… VEGF-A released by the gastric cancer cells is considered to be the major pro-angiogenic
factor involved in gastric tumorigenesis [40]. Moreover, the expression of VEGF-A increases …

… agents and vascular endothelial growth factor (VEGF) inhibition are … EGFR is a therapeutic
strategy in development in gastric … after potentially curative surgery, it is a good target for novel …

… Studies on the impact of EGFR expression on survival and … stage II/III GC who underwent
curative surgery and adjuvant … GC, circulating VEGF, VEGF-C, and VEGF-D expression were …

… gastric cancer treatment. Other promising biomarkers for targeted therapies that have shown
relevance in clinical trials are VEGF … Studies analyzing the impact of EGFR expression on …

… Therefore, VEGF antibody and VEGFR antagonists are used … with gastric cancer with
evidence of EGFR expression benefit … the routine use of EGFR for the detection of gastric cancer. …

… of resistance to EGFR-targeted … , VEGF expression has been found in approximately 40%
of GC [35]. Bevacizumab is an anti-VEGF-A monoclonal antibody that inhibits circulating VEGF-…

… studies considered VEGF and its receptors as possible biomarkers in gastric carcinoma, the
… All claims expressed in this article are solely those of the authors and do not necessarily …

… Aim of the research –to analyze secretion of vascular endothelial growth factor (VEGF) and
… tissue in gastric cancer and colon cancer was combined with hypo-expression of EGFR by …